Cargando…

Differences in risk for SARS-CoV-2 infection among healthcare workers

Healthcare workers (HCWs) are a risk group for SARS-CoV-2 infection, but which healthcare work that conveys risk and to what extent such risk can be prevented is not clear. Starting on April 24th, 2020, all employees at work (n = 15,300) at the Karolinska University Hospital, Stockholm, Sweden were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elfström, K. Miriam, Blomqvist, Jonas, Nilsson, Peter, Hober, Sophia, Pin, Elisa, Månberg, Anna, Pimenoff, Ville N., Arroyo Mühr, Laila Sara, Lundgren, Kalle Conneryd, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379088/ https://www.ncbi.nlm.nih.gov/pubmed/34458081 http://dx.doi.org/10.1016/j.pmedr.2021.101518

Ejemplares similares

Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers
por: Pimenoff, Ville N., et al.
Publicado: (2021)

Risk for SARS-CoV-2 infection in healthcare workers outside hospitals: A real-life immuno-virological study during the first wave of the COVID-19 epidemic
por: Fröberg, Maria, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 and risk of past or future sick leave
por: Dillner, Joakim, et al.
Publicado: (2021)

Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care
por: Klevebro, Susanna, et al.
Publicado: (2021)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Severe features during outbreak but low mortality observed immediately before and after a March–May 2020 COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N., et al.
Publicado: (2021)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

Comparison of DNA and RNA sequencing of total nucleic acids from human cervix for metagenomics
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2021)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

De novo sequence assembly requires bioinformatic checking of chimeric sequences
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

A pilot study of risk-stratified cervical cancer screening
por: Wang, Jiangrong, et al.
Publicado: (2022)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Viruses in case series of tumors: Consistent presence in different cancers in the same subject
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2017)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Corrigendum: Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Negative-Pressure Wound Therapy Versus Standard Treatment of Adult Patients With Conflict-Related Extremity Wounds: Protocol for a Randomized Controlled Trial
por: Älgå, Andreas, et al.
Publicado: (2018)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020)

Assessment of bacterial and viral gut communities in healthy and tumoral colorectal tissue using RNA and DNA deep sequencing
por: Garcia‐Serrano, Ainhoa, et al.
Publicado: (2023)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Atypical glandular cells and development of cervical cancer: Population‐based cohort study
por: Norman, Ingrid, et al.
Publicado: (2022)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
por: Asplund Högelin, Klara, et al.
Publicado: (2021)

Improved Surgical Outcome with Double Incision and Free Nipple Graft in Gender Confirmation Mastectomy
por: Kamali, Alexander, et al.
Publicado: (2021)

Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
por: Gray, Penelope, et al.
Publicado: (2021)

Drug-induced tumor-specific cytotoxicity in a whole tissue ex vivo model of human pancreatic ductal adenocarcinoma
por: Moro, Carlos Fernández, et al.
Publicado: (2022)

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
por: Lehtinen, Matti, et al.
Publicado: (2022)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)

Human exposome assessment platform
por: Merino Martinez, Roxana, et al.
Publicado: (2021)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_drin4su9kml71fklkc148j888b